XML 26 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurement
6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurement Fair value measurement Refer to Note 2 of JPMorgan Chase’s 2021 Form 10-K for a discussion of the Firm’s valuation methodologies for assets, liabilities and lending-related commitments measured at fair value and the fair value hierarchy.
The following table presents the assets and liabilities reported at fair value as of June 30, 2022, and December 31, 2021, by major product category and fair value hierarchy.
Assets and liabilities measured at fair value on a recurring basis
Fair value hierarchy
Derivative
netting
adjustments
(f)
June 30, 2022 (in millions)Level 1Level 2Level 3Total fair value
Federal funds sold and securities purchased under resale agreements$ $319,187 $1 $ $319,188 
Securities borrowed 73,995   73,995 
Trading assets:
Debt instruments:
Mortgage-backed securities:
U.S. GSEs and government agencies(a)
 50,166 803  50,969 
Residential – nonagency 2,191 14  2,205 
Commercial – nonagency 1,646 10  1,656 
Total mortgage-backed securities 54,003 827  54,830 
U.S. Treasury, GSEs and government agencies(a)
64,403 10,013   74,416 
Obligations of U.S. states and municipalities 6,938 7  6,945 
Certificates of deposit, bankers’ acceptances and commercial paper
 677   677 
Non-U.S. government debt securities33,142 47,976 205  81,323 
Corporate debt securities 25,943 574  26,517 
Loans 6,900 898  7,798 
Asset-backed securities 2,711 20  2,731 
Total debt instruments97,545 155,161 2,531  255,237 
Equity securities84,045 2,429 661  87,135 
Physical commodities(b)
3,413 19,480 2  22,895 
Other 18,861 87  18,948 
Total debt and equity instruments(c)
185,003 195,931 3,281  384,215 
Derivative receivables:
Interest rate3,682 246,878 2,584 (231,214)21,930 
Credit 12,847 731 (11,971)1,607 
Foreign exchange254 260,425 1,175 (233,688)28,166 
Equity 72,297 3,884 (66,004)10,177 
Commodity 48,168 581 (29,312)19,437 
Total derivative receivables3,936 640,615 8,955 (572,189)81,317 
Total trading assets(d)
188,939 836,546 12,236 (572,189)465,532 
Available-for-sale securities:
Mortgage-backed securities:
U.S. GSEs and government agencies(a)
 63,689   63,689 
Residential – nonagency 5,475   5,475 
Commercial – nonagency 2,153   2,153 
Total mortgage-backed securities 71,317   71,317 
U.S. Treasury and government agencies109,984    109,984 
Obligations of U.S. states and municipalities 10,133   10,133 
Non-U.S. government debt securities6,597 9,211   15,808 
Corporate debt securities 133 186  319 
Asset-backed securities:
Collateralized loan obligations 10,972   10,972 
Other 3,536   3,536 
Total available-for-sale securities116,581 105,302 186  222,069 
Loans (e)
 45,036 2,020  47,056 
Mortgage servicing rights  7,439  7,439 
Other assets(d)
9,969 7,752 408  18,129 
Total assets measured at fair value on a recurring basis$315,489 $1,387,818 $22,290 $(572,189)$1,153,408 
Deposits$ $11,238 $2,032 $ $13,270 
Federal funds purchased and securities loaned or sold under repurchase agreements
 156,340   156,340 
Short-term borrowings 14,778 2,101  16,879 
Trading liabilities:
Debt and equity instruments(c)
104,871 32,964 56  137,891 
Derivative payables:
Interest rate2,706 232,342 2,164 (225,687)11,525 
Credit 10,841 482 (10,433)890 
Foreign exchange240 258,116 930 (240,045)19,241 
Equity 71,601 5,118 (66,555)10,164 
Commodity 42,434 555 (32,392)10,597 
Total derivative payables2,946 615,334 9,249 (575,112)52,417 
Total trading liabilities107,817 648,298 9,305 (575,112)190,308 
Accounts payable and other liabilities6,752 2,928 73  9,753 
Beneficial interests issued by consolidated VIEs 5   5 
Long-term debt 42,985 23,077  66,062 
Total liabilities measured at fair value on a recurring basis$114,569 $876,572 $36,588 $(575,112)$452,617 
Fair value hierarchy
Derivative
netting
adjustments
(f)
December 31, 2021 (in millions)Level 1Level 2Level 3Total fair value
Federal funds sold and securities purchased under resale agreements$— $252,720 $— $— $252,720 
Securities borrowed— 81,463 — — 81,463 
Trading assets:
Debt instruments:
Mortgage-backed securities:
U.S. GSEs and government agencies(a)
— 38,944 265 — 39,209 
Residential – nonagency— 2,358 28 — 2,386 
Commercial – nonagency— 1,506 10 — 1,516 
Total mortgage-backed securities— 42,808 303 — 43,111 
U.S. Treasury, GSEs and government agencies(a)
68,527 9,181 — — 77,708 
Obligations of U.S. states and municipalities— 7,068 — 7,075 
Certificates of deposit, bankers’ acceptances and commercial paper
— 852 — — 852 
Non-U.S. government debt securities26,982 44,581 81 — 71,644 
Corporate debt securities— 24,491 332 — 24,823 
Loans— 7,366 708 — 8,074 
Asset-backed securities— 2,668 26 — 2,694 
Total debt instruments95,509 139,015 1,457 — 235,981 
Equity securities86,904 1,741 662 — 89,307 
Physical commodities(b)
5,357 20,788 — — 26,145 
Other— 24,850 160 — 25,010 
Total debt and equity instruments(c)
187,770 186,394 2,279 — 376,443 
Derivative receivables:
Interest rate1,072 267,493 

2,020 (248,611)21,974 
Credit— 9,321 518 (8,808)1,031 
Foreign exchange134 168,590 

855 (156,954)12,625 
Equity— 65,139 3,492 (58,650)9,981 
Commodity— 26,232 421 (15,183)11,470 
Total derivative receivables1,206 536,775 

7,306 (488,206)57,081 
Total trading assets(d)
188,976 723,169 

9,585 (488,206)433,524 
Available-for-sale securities:
Mortgage-backed securities:
U.S. GSEs and government agencies(a)
72,539 — — 72,543 
Residential – nonagency— 6,070 — — 6,070 
Commercial – nonagency— 4,949 — — 4,949 
Total mortgage-backed securities83,558 — — 83,562 
U.S. Treasury and government agencies177,463 — — — 177,463 
Obligations of U.S. states and municipalities— 15,860 — — 15,860 
Non-U.S. government debt securities5,430 10,779 — — 16,209 
Corporate debt securities— 160 161 — 321 
Asset-backed securities:
Collateralized loan obligations— 9,662 — — 9,662 
Other— 5,448 — — 5,448 
Total available-for-sale securities182,897 125,467 161 — 308,525 
Loans(e)
— 56,887 1,933 — 58,820 
Mortgage servicing rights— — 5,494 — 5,494 
Other assets(d)
9,558 4,139 306 — 14,003 
Total assets measured at fair value on a recurring basis$381,431 $1,243,845 

$17,479 

$(488,206)$1,154,549 
Deposits$— $9,016 $2,317 $— $11,333 
Federal funds purchased and securities loaned or sold under repurchase agreements
— 126,435 — — 126,435 
Short-term borrowings— 17,534 2,481 — 20,015 
Trading liabilities:
Debt and equity instruments(c)
87,831 26,716 30 — 114,577 
Derivative payables:
Interest rate981 237,714 

2,036 (232,537)8,194 
Credit— 10,468 

444 (10,032)880 
Foreign exchange123 174,349 

1,274 (161,649)14,097 
Equity— 72,609 

7,118 (62,494)17,233 
Commodity— 26,600 

1,328 (18,216)9,712 
Total derivative payables1,104 521,740 

12,200 (484,928)50,116 
Total trading liabilities88,935 548,456 

12,230 (484,928)164,693 
Accounts payable and other liabilities5,115 467 

69 — 5,651 
Beneficial interests issued by consolidated VIEs— 12 

— — 12 
Long-term debt— 50,560 

24,374 — 74,934 
Total liabilities measured at fair value on a recurring basis$94,050 $752,480 

$41,471 $(484,928)$403,073 
(a)At June 30, 2022, and December 31, 2021, included total U.S. GSE obligations of $70.0 billion and $73.9 billion, respectively, which were mortgage-related.
(b)Physical commodities inventories are generally accounted for at the lower of cost or net realizable value. “Net realizable value” is a term defined in U.S. GAAP as not exceeding fair value less costs to sell (“transaction costs”). Transaction costs for the Firm’s physical commodities inventories are either not applicable or immaterial to the value of the inventory. Therefore, net realizable value approximates fair value for the Firm’s physical commodities inventories. When fair value hedging has been applied (or when net realizable value is below cost), the carrying value of physical commodities approximates fair value, because under fair value hedge accounting, the cost basis is adjusted for changes in fair value. Refer to Note 4 for a further discussion of the Firm’s hedge accounting relationships. To provide consistent fair value disclosure information, all physical commodities inventories have been included in each period presented.
(c)Balances reflect the reduction of securities owned (long positions) by the amount of identical securities sold but not yet purchased (short positions).
(d)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient are not required to be classified in the fair value hierarchy. At June 30, 2022, and December 31, 2021, the fair values of these investments, which include certain hedge funds, private equity funds, real estate and other funds, were $856 million and $801 million, respectively. Included in these balances at June 30, 2022, and December 31, 2021, were trading assets of $45 million and $51 million, respectively, and other assets of $811 million and $750 million, respectively.
(e)At June 30, 2022, and December 31, 2021, included $13.5 billion and $26.2 billion, respectively, of residential first-lien mortgages, and $7.7 billion and $8.2 billion, respectively, of commercial first-lien mortgages. Residential mortgage loans include conforming mortgage loans originated with the intent to sell to U.S. GSEs and government agencies of $4.4 billion and $13.6 billion, respectively.
(f)As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. The level 3 balances would be reduced if netting were applied, including the netting benefit associated with cash collateral.
Level 3 valuations
Refer to Note 2 of JPMorgan Chase’s 2021 Form 10-K for further information on the Firm’s valuation process and a detailed discussion of the determination of fair value for individual financial instruments.
The following table presents the Firm’s primary level 3 financial instruments, the valuation techniques used to measure the fair value of those financial instruments, the significant unobservable inputs, the range of values for those inputs and the weighted or arithmetic averages of such inputs. While the determination to classify an instrument within level 3 is based on the significance of the unobservable inputs to the overall fair value measurement, level 3 financial instruments typically include observable components (that is, components that are actively quoted and can be validated to external sources) in addition to the unobservable components. The level 1 and/or level 2 inputs are not included in the table. In addition, the Firm manages the risk of the observable components of level 3 financial instruments using securities and derivative positions that are classified within levels 1 or 2 of the fair value hierarchy.
The range of values presented in the table is representative of the highest and lowest level input used to value the significant groups of instruments within a product/instrument classification. Where provided, the weighted averages of the input values presented in the table are calculated based on the fair value of the instruments that the input is being used to value.
In the Firm’s view, the input range, weighted and arithmetic average values do not reflect the degree of input uncertainty or an assessment of the reasonableness of the Firm’s estimates and assumptions. Rather, they reflect the characteristics of the various instruments held by the Firm and the relative distribution of instruments within the range of characteristics. For example, two option contracts may have similar levels of market risk exposure and valuation uncertainty, but may have significantly different implied volatility levels because the option contracts have different underlyings, tenors, or strike prices. The input range and weighted average values will therefore vary from period-to-period and parameter-to-parameter based on the characteristics of the instruments held by the Firm at each balance sheet date.

Level 3 inputs(a)
June 30, 2022
Product/Instrument
Fair value
(in millions)
Principal valuation technique
Unobservable inputs(g)
Range of input values
Average(i)
Residential mortgage-backed securities and loans(b)
$1,731 Discounted cash flowsYield3%18%6%
Prepayment speed2%12%9%
Conditional default rate0%5%0%
Loss severity0%110%3%
Commercial mortgage-backed securities and loans(c)
418 Market comparablesPrice$0$103$87
Corporate debt securities760 Market comparablesPrice$0$243$94
Loans(d)
1,596 Market comparablesPrice$0$356$89
Non-U.S. government debt securities205 Market comparablesPrice$6$109$94
Net interest rate derivatives415 Option pricingInterest rate volatility22 bps836 bps141 bps
Interest rate spread volatility11 bps23 bps15 bps
Interest rate correlation(82)%89%17%
IR-FX correlation(35)%65%6%
Discounted cash flowsPrepayment speed0%30%7%
Net credit derivatives227 Discounted cash flowsCredit correlation30%60%47%
Credit spread1 bps5,308 bps656 bps
Recovery rate12%67%45%
22 Market comparablesPrice$0$115$79
Net foreign exchange derivatives338 Option pricingIR-FX correlation(40)%65%18%
(93)Discounted cash flowsPrepayment speed9%9%
Interest rate curve2%42%11%
Net equity derivatives(1,234)Option pricing
Forward equity price(h)
80%138%100%
Equity volatility4%127%36%
Equity correlation17%98%55%
Equity-FX correlation(77)%59%(26)%
Equity-IR correlation15%50%28%
Net commodity derivatives26 Option pricingOil commodity forward$128 / BBL$347 / BBL$237 / BBL
Industrial metals commodity forward$1,854 / MT$3,313 / MT$2,583 / MT
Commodity volatility4%150%77%
Commodity correlation(30)%98%34%
MSRs7,439 Discounted cash flows
Refer to Note 14
Long-term debt, short-term borrowings, and deposits(e)
26,284 Option pricingInterest rate volatility22 bps836 bps141 bps
Interest rate correlation(82)%89%17%
IR-FX correlation(35)%65%6%
Equity correlation17%98%55%
Equity-FX correlation(77)%59%(26)%
Equity-IR correlation15%50%28%
926 Discounted cash flowsCredit correlation30%60%47%
Other level 3 assets and liabilities, net(f)
1,057 
(a)The categories presented in the table have been aggregated based upon the product type, which may differ from their classification on the Consolidated balance sheets. Furthermore, the inputs presented for each valuation technique in the table are, in some cases, not applicable to every instrument valued using the technique as the characteristics of the instruments can differ.
(b)Comprises U.S. GSE and government agency securities of $803 million, nonagency securities of $14 million and non-trading loans of $914 million.
(c)Comprises nonagency securities of $10 million, trading loans of $40 million and non-trading loans of $368 million.
(d)Comprises trading loans of $858 million and non-trading loans of $738 million.
(e)Long-term debt, short-term borrowings and deposits include structured notes issued by the Firm that are financial instruments that typically contain embedded derivatives. The estimation of the fair value of structured notes includes the derivative features embedded within the instrument. The significant unobservable inputs are broadly consistent with those presented for derivative receivables.
(f)Includes equity securities of $918 million including $257 million in Other Assets, for which quoted prices are not readily available and the fair value is generally based on internal valuation techniques such as EBITDA multiples and comparable analysis. All other level 3 assets and liabilities are insignificant both individually and in aggregate.
(g)Price is a significant unobservable input for certain instruments. When quoted market prices are not readily available, reliance is generally placed on price-based internal valuation techniques. The price input is expressed assuming a par value of $100.
(h)Forward equity price is expressed as a percentage of the current equity price.
(i)Amounts represent weighted averages except for derivative related inputs where arithmetic averages are used.
Changes in and ranges of unobservable inputs
Refer to Note 2 of JPMorgan Chase’s 2021 Form 10-K for a discussion of the impact on fair value of changes in unobservable inputs and the relationships between unobservable inputs as well as a description of attributes of the underlying instruments and external market factors that affect the range of inputs used in the valuation of the Firm’s positions.
Changes in level 3 recurring fair value measurements
The following tables include a rollforward of the Consolidated balance sheets amounts (including changes in fair value) for financial instruments classified by the Firm within level 3 of the fair value hierarchy for the three and six months ended June 30, 2022 and 2021. When a determination is made to classify a financial instrument within level 3, the determination is based on the significance of the unobservable inputs to the overall fair value measurement. However, level 3 financial instruments typically include, in addition to the unobservable or level 3 components, observable components (that is, components that are actively quoted and can be validated to external sources); accordingly, the gains and losses in the table below include changes in fair value due in part to observable factors that are part of the valuation methodology. Also, the Firm risk-manages the observable components of level 3 financial instruments using securities and derivative positions that are classified within level 1 or 2 of the fair value hierarchy; as these level 1 and level 2 risk management instruments are not included below, the gains or losses in the following tables do not reflect the effect of the Firm’s risk management activities related to such level 3 instruments.
Fair value measurements using significant unobservable inputs
Three months ended June 30, 2022
(in millions)
Fair value at
  April 1,
2022
Total realized/unrealized gains/(losses)Transfers into
level 3
Transfers (out of) level 3Fair value at
June 30, 2022
Change in unrealized gains/(losses) related
to financial instruments held at June 30, 2022
Purchases(g)
Sales
Settlements(h)
Assets:(a)
Federal funds sold and securities purchased under resale agreements$ $ $ $ $ $1 $ $1 $ 
Trading assets:
Debt instruments:
Mortgage-backed securities:
U.S. GSEs and government agencies
$286 $(1)$643 $(118)$(7)$ $ $803 $(2)
Residential – nonagency10  5  (1)  14  
Commercial – nonagency
10       10  
Total mortgage-backed securities
306 (1)648 (118)(8)  827 (2)
Obligations of U.S. states and municipalities
7       7  
Non-U.S. government debt securities
133 (9)177 (86) 6 (16)205 (8)
Corporate debt securities293 (16)272 (12) 57 (20)574 (16)
Loans1,049 (33)122 (164)(152)254 (178)898 (32)
Asset-backed securities28  1 (10) 1  20  
Total debt instruments1,816 (59)1,220 (390)(160)318 (214)2,531 (58)
Equity securities663 (99)98 (61) 106 (46)661 (90)
Physical commodities  2     2  
Other175 66 6  (158) (2)87 60 
Total trading assets – debt and equity instruments
2,654 (92)
(c)
1,326 (451)(318)424 (262)3,281 (88)
(c)
Net derivative receivables:(b)
Interest rate367 160 99 (135)105 44 (220)420 204 
Credit44 264 4 (3)(65)1 4 249 255 
Foreign exchange76 193 15 (19)(38)24 (6)245 174 
Equity(2,583)1,838 162 (466)(140)(227)182 (1,234)1,788 
Commodity(414)382 18 (69)112 (1)(2)26 423 
Total net derivative receivables
(2,510)2,837 
(c)
298 (692)(26)(159)(42)(294)2,844 
(c)
Available-for-sale securities:
Mortgage-backed securities         
Corporate debt securities205 (19)     186 (19)
Total available-for-sale securities
205 (19)
(d)
     186 (19)
(d)
Loans2,072 (82)
(c)
273 (95)(250)226 (124)2,020 (80)
(c)
Mortgage servicing rights7,294 654 
(e)
341 (614)(236)  7,439 654 
(e)
Other assets341 116 
(c)
5 (28)(20) (6)408 116 
(c)
Fair value measurements using significant unobservable inputs
Three months ended
June 30, 2022
(in millions)
Fair value at
  April 1,
2022
Total realized/unrealized (gains)/lossesTransfers into
level 3
Transfers (out of) level 3Fair value at
June 30, 2022
Change in unrealized (gains)/losses related
to financial instruments held at June 30, 2022
PurchasesSalesIssuances
Settlements(h)
Liabilities:(a)
Deposits$2,121 $(160)
(c)(f)
$ $ $138 $(21)$ $(46)$2,032 $(160)
(c)(f)
Short-term borrowings2,146 14 
(c)(f)
  963 (1,036)14  2,101 93 
(c)(f)
Trading liabilities – debt and equity instruments
41 1 
(c)
(20)4   30  56 1 
(c)
Accounts payable and other liabilities
108 (2)
(c)
(28)1    (6)73 (2)
(c)
Beneficial interests issued by consolidated VIEs
  

        

Long-term debt24,394 (2,640)
(c)(f)
  3,470 (2,045)179 (281)23,077 (2,613)
(c)(f)
Fair value measurements using significant unobservable inputs
Three months ended
June 30, 2021
(in millions)
Fair value at
April 1,
2021
Total realized/unrealized gains/(losses)Transfers into
level 3
Transfers (out of) level 3Fair value at
June 30, 2021
Change in unrealized gains/(losses) related
to financial instruments held at June 30, 2021
Purchases(g)
Sales
Settlements(h)
Assets:(a)
Trading assets:
Debt instruments:
Mortgage-backed securities:
U.S. GSEs and government agencies
$397 $(33)$$(8)$(28)$$(1)$329 $(34)
Residential – nonagency32 — (21)(1)— — 16 — 
Commercial – nonagency— 11 — (3)— — 10 
Total mortgage-backed securities
431 (33)18 (29)(32)(1)355 (33)
Obligations of U.S. states and municipalities
— — — — — — — 
Non-U.S. government debt securities
177 84 (79)— — — 183 (1)
Corporate debt securities370 30 228 (154)— 28 (15)487 30 
Loans832 (1)294 (85)(125)85 (205)795 
Asset-backed securities54 10 (36)(1)— — 35 
Total debt instruments1,872 634 (383)(158)114 (221)1,863 (2)
Equity securities688 23 (27)— 24 (26)690 15 
Other122 36 — (26)(95)47 19 
Total trading assets – debt and equity instruments
2,682 20 
(c)
693 (410)(184)141 (342)2,600 32 
(c)
Net derivative receivables:(b)
Interest rate149 524 18 (9)(657)

(2)(45)(22)198 
Credit(4)(34)(2)17 (6)11 (17)(13)
Foreign exchange(539)37 (48)(12)(24)(583)(104)
Equity(3,834)(941)

281 (407)

600 

(91)(544)

(4,936)(942)
Commodity(911)(347)(81)165 — (1,167)(198)
Total net derivative receivables
(5,139)(796)
(c)
343 (547)

113 

(98)(601)

(6,725)(1,059)
(c)
Available-for-sale securities:
Mortgage-backed securities  

  

 

  

  
Corporate debt securities— — — — — — — — — 
Total available-for-sale securities
— — 
(d)
— — — — — — — 
(d)
Loans1,823 
(c)
240 (135)(318)445 (328)1,734 (11)
(c)
Mortgage servicing rights4,470 (528)
(e)
814 (25)(182)— — 4,549 (528)
(e)
Other assets511 31 
(c)
— (27)— (1)518 35 
(c)
Fair value measurements using significant unobservable inputs
Three months ended
June 30, 2021
(in millions)
Fair value at
April 1,
2021
Total realized/unrealized (gains)/lossesTransfers into
level 3
Transfers (out of) level 3Fair value at
June 30, 2021
Change in unrealized (gains)/losses related
to financial instruments held at June 30, 2021
PurchasesSalesIssuances
Settlements(h)
Liabilities:(a)
Deposits$2,652 $47 
(c)(f)
$— $— $150 $(93)$$(73)$2,684 $47 
(c)(f)
Short-term borrowings3,664 (283)
(c)(f)
— — 1,395 (1,706)(4)3,075 35 
(c)(f)
Trading liabilities – debt and equity instruments
60 (1)
(c)
(27)13 — — — (9)36 — 

Accounts payable and other liabilities
61 (9)
(c)
— — — — — (1)51 (8)
(c)
Beneficial interests issued by consolidated VIEs
— — 

— — — — — — — — 

Long-term debt22,575 714 
(c)(f)
— — 3,469 (3,089)

(149)23,527 

708 
(c)(f)
Fair value measurements using significant unobservable inputs
Six months ended June 30, 2022
(in millions)
Fair value at
Jan 1,
2022
Total realized/unrealized gains/(losses)Transfers into
level 3
Transfers (out of) level 3Fair value at
June 30, 2022
Change in unrealized gains/(losses) related
to financial instruments held at June 30, 2022
Purchases(g)
Sales
Settlements(h)
Assets:(a)
Federal funds sold and securities purchased under resale agreements$— $— $— $— $— $$— $$— 
Trading assets:
Debt instruments:
Mortgage-backed securities:
U.S. GSEs and government agencies
$265 $26 $665 $(125)$(28)$— $— $803 $24 
Residential – nonagency28 — — (12)— (7)14 (1)
Commercial – nonagency10 — — — — — — 10 — 
Total mortgage-backed securities
303 26 670 (125)(40)— (7)827 23 
Obligations of U.S. states and municipalities
— — — — — — — 
Non-U.S. government debt securities
81 (42)405 (266)— 43 (16)205 (106)
Corporate debt securities332 (35)333 (71)(37)98 (46)574 (44)
Loans708 (37)419 (262)(159)525 (296)898 (13)
Asset-backed securities26 — (10)— (3)20 — 
Total debt instruments1,457 (88)1,829 (734)(236)671 (368)2,531 (140)
Equity securities662 (912)321 (301)— 959 (68)661 (474)
Physical Commodities— — — — — — — 
Other160 67 26 — (163)— (3)87 70 
Total trading assets – debt and equity instruments
2,279 (933)
(c)
2,178 (1,035)(399)1,630 (439)3,281 (544)
(c)
Net derivative receivables:(b)
Interest rate(16)393 225 (229)256 

17 (226)420 428 
Credit74 331 (7)(161)(2)249 330 
Foreign exchange(419)538 147 (43)32 18 (28)245 486 
Equity(3,626)2,568 

660 (1,025)

303 

(558)444 

(1,234)2,975 
Commodity(907)804 68 (206)268 (1)— 26 469 
Total net derivative receivables
(4,894)4,634 
(c)
1,108 (1,510)

698 

(526)196 

(294)4,688 
(c)
Available-for-sale securities:
Mortgage-backed securities— — 

— — 

— 

— — 

— — 
Corporate debt securities161 17 — — — — 186 
Total available-for-sale securities
161 
(d)
17 — — — — 186 
(d)
Loans1,933 16 
(c)
394 (100)(531)616 (308)2,020 (24)
(c)
Mortgage servicing rights5,494 1,613 
(e)
1,471 (671)(468)— — 7,439 1,613 
(e)
Other assets306 125 
(c)
46 (28)(37)(6)408 119 
(c)
Fair value measurements using significant unobservable inputs
Six months ended June 30, 2022
(in millions)
Fair value at
Jan 1,
2022
Total realized/unrealized (gains)/lossesTransfers into
level 3
Transfers (out of) level 3Fair value at
June 30, 2022
Change in unrealized (gains)/losses related
to financial instruments held at June 30, 2022
PurchasesSalesIssuances
Settlements(h)
Liabilities:(a)
Deposits$2,317 $(302)
(c)(f)
$— $— $246 $(69)$— $(160)$2,032 $(298)
(c)(f)
Short-term borrowings2,481 (387)
(c)(f)
— — 2,386 (2,383)15 (11)2,101 
(c)(f)
Trading liabilities – debt and equity instruments
30 (16)
(c)
(34)34 — — 44 (2)56 15 
(c)
Accounts payable and other liabilities
69 (6)
(c)
(28)43 — — (6)73 (6)
(c)
Long-term debt24,374 (4,308)
(c)(f)
— — 7,520 (4,521)

442 (430)23,077 

(4,151)
(c)(f)
    
Fair value measurements using significant unobservable inputs
Six months ended
June 30, 2021
(in millions)
Fair value at
Jan 1,
2021
Total realized/unrealized gains/(losses)Transfers into
level 3
Transfers (out of) level 3Fair value at
June 30, 2021
Change in unrealized gains/(losses) related
to financial instruments held at June 30, 2021
Purchases(g)
Sales
Settlements(h)
Assets:(a)
Trading assets:
Debt instruments:
Mortgage-backed securities:
U.S. GSEs and government agencies
$449 $(10)$$(56)$(61)$$(1)$329 $(12)
Residential – nonagency28 15 (24)(3)— (1)16 — 
Commercial – nonagency— 11 (1)(3)— — 10 — 
Total mortgage-backed securities
480 (9)33 (81)(67)(2)355 (12)
Obligations of U.S. states and municipalities
— — — — — — — 
Non-U.S. government debt securities
182 (8)202 (186)(7)— — 183 (7)
Corporate debt securities507 15 319 (300)— 113 (167)487 14 
Loans893 566 (237)(126)175 (482)795 
Asset-backed securities28 38 (39)(1)— 35 
Total debt instruments2,098 11 1,158 (843)(201)291 (651)1,863 
Equity securities476 253 (70)— 78 (50)690 13 
Other49 48 101 — (55)(99)47 28 
Total trading assets – debt and equity instruments
2,623 62 
(c)
1,512 (913)(256)372 (800)2,600 46 
(c)
Net derivative receivables:(b)
Interest rate258 969 71 (102)(1,191)

55 (82)(22)233 
Credit(224)149 (4)44 (9)25 (17)134 
Foreign exchange(434)(198)39 (54)99 11 (46)(583)32 
Equity(3,862)(918)

475 (1,245)

726 

19 (131)

(4,936)(1,258)
Commodity(731)(593)10 (294)444 (1)(2)(1,167)(554)
Total net derivative receivables
(4,993)(591)
(c)
597 (1,699)

122 

75 (236)

(6,725)(1,413)
(c)
Available-for-sale securities:
Mortgage-backed securities— — 

— — 

— 

— — 

— — 
Corporate debt securities— — — — — — — — — 
Total available-for-sale securities
— — 
(d)
— — — — — — — 
(d)
Loans2,305 (66)
(c)
307 (325)(519)600 (568)1,734 (72)
(c)
Mortgage servicing rights3,276 269 
(e)
1,397 (24)(369)— — 4,549 269 
(e)
Other assets538 44 
(c)
(18)(52)— (1)518 63 
(c)
Fair value measurements using significant unobservable inputs
Six months ended
June 30, 2021
(in millions)
Fair value at
Jan 1,
2021
Total realized/unrealized (gains)/lossesTransfers into
level 3
Transfers (out of) level 3Fair value at
June 30, 2021
Change in unrealized (gains)/losses related
to financial instruments held at June 30, 2021
PurchasesSalesIssuances
Settlements(h)
Liabilities:(a)
Deposits$2,913 $(56)
(c)(f)
$— $— $219 $(188)$$(206)$2,684 $(56)
(c)(f)
Short-term borrowings2,420 (396)
(c)(f)
— — 4,313 (3,212)(59)3,075 18 
(c)(f)
Trading liabilities – debt and equity instruments
51 (4)
(c)
(92)34 — — 59 (12)36 10 
(c)
Accounts payable and other liabilities
68 (10)
(c)
— — — — (8)51 (10)
(c)
Long-term debt23,397 406 
(c)(f)
— — 6,934 (6,738)

18 (490)23,527 

305 
(c)(f)
(a)Level 3 assets at fair value as a percentage of total Firm assets at fair value (including assets measured at fair value on a nonrecurring basis) were 2% at both June 30, 2022 and December 31, 2021. Level 3 liabilities at fair value as a percentage of total Firm liabilities at fair value (including liabilities measured at fair value on a nonrecurring basis) were 8% and 10% at June 30, 2022 and December 31, 2021, respectively.
(b)All level 3 derivatives are presented on a net basis, irrespective of the underlying counterparty.
(c)Predominantly reported in principal transactions revenue, except for changes in fair value for CCB mortgage loans and lending-related commitments originated with the intent to sell, and mortgage loan purchase commitments, which are reported in mortgage fees and related income.
(d)Realized gains/(losses) on AFS securities are reported in investment securities gains/(losses). Unrealized gains/(losses) are reported in OCI. There were no realized gains/(losses) recorded in income on AFS securities for the three and six months ended June 30, 2022 and 2021, respectively. Unrealized gains/(losses) recorded on AFS securities in OCI were $(19) million and zero for the three months ended June 30, 2022 and 2021, respectively and $8 million and zero for the six months ended June 30, 2022 and 2021, respectively.
(e)Changes in fair value for MSRs are reported in mortgage fees and related income.
(f)Realized (gains)/losses due to DVA for fair value option elected liabilities are reported in principal transactions revenue, and were not material for the three and six months ended June 30, 2022 and 2021. Unrealized (gains)/losses are reported in OCI, and were $(344) million and $5 million for the three months ended June 30, 2022 and 2021, respectively and $(574) million and $(17) million for the six months ended June 30, 2022 and 2021, respectively.
(g)Loan originations are included in purchases.
(h)Includes financial assets and liabilities that have matured, been partially or fully repaid, impacts of modifications, deconsolidations associated with beneficial interests in VIEs and other items.
Level 3 analysis
Consolidated balance sheets changes
The following describes significant changes to level 3 assets since December 31, 2021, for those items measured at fair value on a recurring basis. Refer to Assets and liabilities measured at fair value on a nonrecurring basis on page 106 for further information on changes impacting items measured at fair value on a nonrecurring basis.
Three and six months ended June 30, 2022
Level 3 assets were $22.3 billion at June 30, 2022, reflecting an increase of $329 million from March 31, 2022, and an increase of $4.8 billion from December 31, 2021.
The increase for the six months ended June 30, 2022 was largely driven by:
$1.6 billion increase in gross derivative receivables due to gains and purchases largely offset by net transfers.
$1.9 billion increase in MSRs.
Refer to Note 14 for information on MSRs.
Refer to the sections below for additional information.
Transfers between levels for instruments carried at fair value on a recurring basis
For the three months ended June 30, 2022, there were no significant transfers from level 2 into level 3.
For the three months ended June 30, 2022, significant transfers from level 3 into level 2 included the following:
$930 million of gross interest rate derivative receivables as a result of an increase in observability and a decrease in the significance of unobservable inputs.
For the six months ended June 30, 2022, significant transfers from level 2 into level 3 included the following:
$1.6 billion of total debt and equity instruments, largely due to equity securities of $959 million driven by a decrease in observability predominantly as a result of restricted access to certain markets.
$1.3 billion of gross equity derivative payables as a result of a decrease in observability and an increase in the significance of unobservable inputs.
For the six months ended June 30, 2022, significant transfers from level 3 into level 2 included the following:
$965 million of gross interest rate derivative receivables as a result of an increase in observability and a decrease in the significance of unobservable inputs.
$920 million and $1.4 billion of gross equity derivative receivables and gross equity derivative payables, respectively, as a result of an increase in observability and a decrease in the significance of unobservable inputs.
For the three and six months ended June 30, 2021, there were no significant transfers from level 2 into level 3.
For the three months ended June 30, 2021, significant transfers from level 3 into level 2 included the following:
$1.0 billion of gross equity derivative receivables as a result of an increase in observability and a decrease in the significance of unobservable inputs.
For the six months ended June 30, 2021, significant transfers from level 3 into level 2 included the following:
$800 million of total debt and equity instruments, largely trading loans, driven by an increase in observability.
$1.3 billion and $1.1 billion of gross equity derivative receivables and gross equity derivative payables, respectively, as a result of an increase in observability and a decrease in the significance of unobservable inputs.
All transfers are based on changes in the observability and/or significance of the valuation inputs and are assumed to occur at the beginning of the quarterly reporting period in which they occur.
Gains and losses
The following describes significant components of total realized/unrealized gains/(losses) for instruments measured at fair value on a recurring basis for the periods indicated. These amounts exclude any effects of the Firm’s risk management activities where the financial instruments are classified as level 1 and 2 of the fair value hierarchy. Refer to Changes in level 3 recurring fair value measurements rollforward tables on pages 99-104 for further information on these instruments.
Three months ended June 30, 2022
$3.4 billion of net gains on assets, largely driven by gains in net equity derivative receivables due to market movements and MSRs reflecting lower prepayment speeds on higher rates.
$2.8 billion of net gains on liabilities, predominantly driven by gains in long-term debt due to market movements.
Three months ended June 30, 2021
$1.3 billion of net losses on assets, driven by losses in net equity derivative receivables due to market movements and losses in MSRs reflecting faster prepayment speeds on lower rates.
$468 million of net losses on liabilities, driven by losses in long-term debt partially offset by gains in short-term borrowings, due to market movements.
Six months ended June 30, 2022
$5.5 billion of net gains on assets, predominantly driven by gains in net equity derivative receivables due to market movements and MSRs reflecting lower prepayment speeds on higher rates.
$5.0 billion of net gains on liabilities, predominantly driven by gains in long-term debt due to market movements.
Six months ended June 30, 2021
$282 million of net losses on assets, driven by losses in net derivative receivables due to market movements largely offset by gains in MSRs reflecting lower prepayment speeds on higher rates.
Refer to Note 14 for information on MSRs.
Credit and funding adjustments — derivatives
The following table provides the impact of credit and funding adjustments on principal transactions revenue in the respective periods, excluding the effect of any associated hedging activities. The FVA presented below includes the impact of the Firm’s own credit quality on the inception value of liabilities as well as the impact of changes in the Firm’s own credit quality over time.
Three months ended June 30,Six months ended June 30,
(in millions)2022202120222021
Credit and funding adjustments:
Derivatives CVA$147 $43 $(165)$283 
Derivatives FVA
7 (45)(51)61 
Refer to Note 2 of JPMorgan Chase’s 2021 Form 10-K for further information about both credit and funding adjustments, as well as information about valuation adjustments on fair value option elected liabilities.
Assets and liabilities measured at fair value on a nonrecurring basis
The following tables present the assets and liabilities held as of June 30, 2022 and 2021, for which nonrecurring fair value adjustments were recorded during the six months ended June 30, 2022 and 2021, by major product category and fair value hierarchy.
Fair value hierarchyTotal fair value
June 30, 2022 (in millions)
Level 1
Level 2
Level 3
Loans$ $1,516 

$665 
(b)
$2,181 
Other assets(a)
 22 1,083 1,105 
Total assets measured at fair value on a nonrecurring basis$ $1,538 $1,748 $3,286 
Accounts payable and other liabilities   293 
 
293 
Total liabilities measured at fair value on a nonrecurring basis$ $ $293 $293 
Fair value hierarchyTotal fair value
June 30, 2021 (in millions)Level 1Level 2Level 3
Loans$— $2,048 

$329 $2,377 
Other assets— 11 831 

842 
Total assets measured at fair value on a nonrecurring basis$— $2,059 $1,160 $3,219 
Accounts payable and other liabilities— — 

Total liabilities measured at fair value on a nonrecurring basis$— $— $$
(a)Primarily includes equity securities without readily determinable fair values that were adjusted based on observable price changes in orderly transactions from an identical or similar investment of the same issuer (measurement alternative). Of the $1.1 billion in level 3 assets measured at fair value on a nonrecurring basis as of June 30, 2022, $985 million related to equity securities adjusted based on the measurement alternative. These equity securities are classified as level 3 due to the infrequency of the observable prices and/or the restrictions on the shares.
(b)Of the $665 million in level 3 assets measured at fair value on a nonrecurring basis as of June 30, 2022, $55 million related to residential real estate loans carried at the net realizable value of the underlying collateral (e.g., collateral-dependent loans). These amounts are classified as level 3 as they are valued using information from broker’s price opinions, appraisals and automated valuation models and discounted based upon the Firm’s experience with actual liquidation values. These discounts ranged from 12% to 56% with a weighted average of 23%.
Nonrecurring fair value changes
The following table presents the total change in value of assets and liabilities for which fair value adjustments have been recognized for the three and six months ended June 30, 2022 and 2021, related to assets and liabilities held at those dates.
Three months ended June 30,Six months ended June 30,
(in millions)2022202120222021
Loans$(80)
 
$(11)

$(91)

$(32)
Other assets(a)
(389)
 
92 

(45)93 
Accounts payable and other liabilities (269)
 

(288)
Total nonrecurring fair value gains/(losses)
$(738)$88 $(424)$67 
(a)Included $(387) million and $102 million for the three months ended June 30, 2022 and 2021, respectively, and $(29) million and $107 million for the six months ended June 30, 2022 and 2021, respectively, of net gains/(losses) as a result of the measurement alternative.
Refer to Note 11 for further information about the measurement of collateral-dependent loans.
Equity securities without readily determinable fair values
The Firm measures certain equity securities without readily determinable fair values at cost less impairment (if any), plus or minus observable price changes from an identical or similar investment of the same issuer (i.e., measurement alternative), with such changes recognized in other income.
In its determination of the new carrying values upon observable price changes, the Firm may adjust the prices if deemed necessary to arrive at the Firm’s estimated fair values. Such adjustments may include adjustments to reflect the different rights and obligations of similar securities, and other adjustments that are consistent with the Firm’s valuation techniques for private equity direct investments.
The following table presents the carrying value of equity securities without readily determinable fair values held as of June 30, 2022 and 2021, that are measured under the measurement alternative and the related adjustments recorded during the periods presented for those securities with observable price changes. These securities are included in the nonrecurring fair value tables when applicable price changes are observable.
 Three months endedSix months ended
 June 30June 30
As of or for the period ended,
(in millions)2022202120222021
Other assets
Carrying value(a)
$4,196 $2,798 $4,196 $2,798 
Upward carrying value changes(b)
76 109 

445 116

Downward carrying value changes/impairment(c)
(463)(7)(474)(9)
(a)The carrying value as of December 31, 2021 was $3.6 billion. The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.
(b)The cumulative upward carrying value changes between January 1, 2018 and June 30, 2022 were $1.5 billion.
(c)The cumulative downward carrying value changes/impairment between January 1, 2018 and June 30, 2022 were $(844) million.
Included in other assets above is the Firm’s interest in approximately 40 million Visa Class B common shares, recorded at a nominal carrying value. These shares are subject to certain transfer restrictions currently and will be convertible into Visa Class A common shares upon final resolution of certain litigation matters involving Visa. The conversion rate of Visa Class B common shares into Visa Class A common shares is 1.6059 at June 30, 2022, and may be adjusted by Visa depending on developments related to the litigation matters.
Additional disclosures about the fair value of financial instruments that are not carried on the Consolidated balance sheets at fair value
The following table presents, by fair value hierarchy classification, the carrying values and estimated fair values at June 30, 2022, and December 31, 2021, of financial assets and liabilities, excluding financial instruments that are carried at fair value on a recurring basis, and their classification within the fair value hierarchy.
June 30, 2022December 31, 2021
Estimated fair value hierarchyEstimated fair value hierarchy
(in billions)Carrying
value
Level 1Level 2Level 3Total estimated
fair value
Carrying
value
Level 1Level 2Level 3Total estimated
fair value
Financial assets
Cash and due from banks$27.2 $27.2 $ $ $27.2 $26.4 $26.4 $— $— $26.4 
Deposits with banks642.0 642.0   642.0 714.4 714.4 — — 714.4 
Accrued interest and accounts receivable
144.5  144.4 0.1 144.5 102.1 — 102.0 0.1 102.1 
Federal funds sold and securities purchased under resale agreements
3.0  3.0  3.0 9.0 — 9.0 — 9.0 
Securities borrowed
128.4  128.4  128.4 124.6 — 124.6 — 124.6 
Investment securities, held-to-maturity
441.6 212.9 202.7  415.6 363.7 183.3 179.3 — 362.6 
Loans, net of allowance for loan losses(a)
1,039.3  193.1 835.0 1,028.1 1,002.5 — 202.1 821.1 1,023.2 
Other113.2  111.8 1.6 113.4 98.7 — 97.4 1.4 98.8 
Financial liabilities
Deposits$2,458.3 $ $2,458.4 $ $2,458.4 $2,451.0 $— $2,451.0 $— $2,451.0 
Federal funds purchased and securities loaned or sold under repurchase agreements
66.4  66.4  66.4 67.9 — 67.9 — 67.9 
Short-term borrowings
41.5  41.5  41.5 33.6 — 33.6 — 33.6 
Accounts payable and other liabilities
272.7  266.7 5.3 272.0 217.6 — 212.1 4.9 217.0 
Beneficial interests issued by consolidated VIEs
10.6  10.6  10.6 10.7 — 10.8 — 10.8 
Long-term debt
222.1  214.9 3.1 218.0 226.0 — 229.5 3.1 232.6 
(a)Fair value is typically estimated using a discounted cash flow model that incorporates the characteristics of the underlying loans (including principal, contractual interest rate and contractual fees) and other key inputs, including expected lifetime credit losses, interest rates, prepayment rates, and primary origination or secondary market spreads. For certain loans, the fair value is measured based on the value of the underlying collateral. Carrying value of the loan takes into account the loan’s allowance for loan losses, which represents the loan’s expected credit losses over its remaining expected life. The difference between the estimated fair value and carrying value of a loan is generally attributable to changes in market interest rates, including credit spreads, market liquidity premiums and other factors that affect the fair value of a loan but do not affect its carrying value.
The majority of the Firm’s lending-related commitments are not carried at fair value on a recurring basis on the Consolidated balance sheets. The carrying value and the estimated fair value of these wholesale lending-related commitments were as follows for the periods indicated.
June 30, 2022December 31, 2021
Estimated fair value hierarchyEstimated fair value hierarchy
(in billions)
Carrying value(a) (b)
Level 1Level 2Level 3Total estimated fair value
Carrying value(a) (b)
Level 1Level 2Level 3Total estimated fair value
Wholesale lending-related commitments
$2.2 $ $ $3.4 $3.4 $2.1 $— $— $2.9 $2.9 
(a)Excludes the current carrying values of the guarantee liability and the offsetting asset, each of which is recognized at fair value at the inception of the guarantees.
(b)Includes the wholesale allowance for lending-related commitments.
The Firm does not estimate the fair value of consumer off-balance sheet lending-related commitments. In many cases, the Firm can reduce or cancel these commitments by providing the borrower notice or, in some cases as permitted by law, without notice. Refer to page 171 of JPMorgan Chase’s 2021 Form 10-K for a further discussion of the valuation of lending-related commitments.